Jung Choi
2020
In 2020, Jung Choi earned a total compensation of $5.9M as Chief Business and Strategy Officer at Global Blood Therapeutics, a 90% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $219,000 |
|---|---|
| Option Awards | $1,582,504 |
| Salary | $433,125 |
| Stock Awards | $3,708,261 |
| Other | $5,000 |
| Total | $5,947,890 |
Choi received $3.7M in stock awards, accounting for 62% of the total pay in 2020.
Choi also received $219K in non-equity incentive plan, $1.6M in option awards, $433.1K in salary and $5K in other compensation.
Rankings
In 2020, Jung Choi's compensation ranked 1,755th out of 13,090 executives tracked by ExecPay. In other words, Choi earned more than 86.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,755 out of 13,090 | 87th |
Division Manufacturing | 672 out of 5,624 | 88th |
Major group Chemicals And Allied Products | 243 out of 2,257 | 89th |
Industry group Drugs | 203 out of 1,957 | 90th |
Industry Pharmaceutical Preparations | 143 out of 1,462 | 90th |
Pay ratio
| Jung Choi's Pay | $5,947,890 |
|---|---|
| Median Employee's Pay | $373,366 |
| Pay Ratio | 16to 1 |
In 2020, the annual total compensation of Jung Choi was $5,947,890.
The annual total compensation of the median employee at Global Blood Therapeutics was $373,366.
The ratio of Jung Choi's pay to the pay of median employee was therefore 16 to one.
Source: SEC filing on April 28, 2021.
Choi's colleagues
We found four more compensation records of executives who worked with Jung Choi at Global Blood Therapeutics in 2020.